Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on March 2, 2006

Arteriosclerosis, Thrombosis, and Vascular Biology. 2006
Published online before print March 2, 2006, doi: 10.1161/01.ATV.0000215638.53414.99
A more recent version of this article appeared on May 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
26/5/1185    most recent
01.ATV.0000215638.53414.99v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, Z.
Right arrow Articles by Jain, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, Z.
Right arrow Articles by Jain, M. K.
Related Collections
Right arrowRelated Article

Submitted on August 29, 2005
Accepted on February 15, 2006

Kruppel-Like Factor 2 Inhibits Protease Activated Receptor-1 Expression and Thrombin-Mediated Endothelial Activation

Zhiyong Lin ; Anne Hamik ; Rajan Jain ; Ajay Kumar ; and Mukesh K. Jain *

From the Program in Cardiovascular Transcriptional Biology, Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass.

* To whom correspondence should be addressed. E-mail: mjain{at}rics.bwh.harvard.edu.

Objective--The serine protease thrombin can dramatically alter endothelial gene expression in a manner that confers a proinflammatory phenotype. Recent studies have identified the Kruppel-like factor 2 (KLF2) as a critical regulator of endothelial gene expression. Herein, we provide evidence that KLF2 inhibits thrombin-mediated endothelial activation via alterations in expression of its principal receptor protease-activated receptor-1 (PAR-1).

Methods and Results--Forced expression of KLF2 in human umbilical vein endothelial cells potently inhibited the ability of thrombin to induce multiple prothrombotic factors (tissue factor, CD40L, plasminogen activator inhibitor-1), cytokines/chemokines (eg, monocyte chemotactic protein-1, interleukin-6 [IL-6], IL-8), and matrix degrading enzymes (eg, matrix metalloproteinases 1, 2, and 9). Mechanistically, KLF2 inhibits PAR-1 expression and, as a consequence, thrombin-mediated nuclear factor {kappa}B (NF-{kappa}B) nuclear accumulation and DNA binding. Conversely, small interfering RNA-mediated knockdown of KLF2 increases PAR-1 expression and thrombin-mediated induction of NF-{kappa}B activation.

Conclusion--These studies identify KLF2 as a novel regulator of PAR-1 expression and thrombin action in endothelial cells.


Key words: Kruppel • thrombin • PAR-1 • transcription • endothelial cells


Related Article:

Flow Perturbation Is Linked to Endothelial PAR Signaling
Wolfram Ruf
Arterioscler Thromb Vasc Biol 2006 26: 962-964. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. Kawanami, G. H. Mahabeleshwar, Z. Lin, G. B. Atkins, A. Hamik, S. M. Haldar, K. Maemura, J. C. LaManna, and M. K. Jain
Kruppel-like Factor 2 Inhibits Hypoxia-inducible Factor 1{alpha} Expression and Function in the Endothelium
J. Biol. Chem., July 31, 2009; 284(31): 20522 - 20530.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Sako, S. Fukuhara, T. Minami, T. Hamakubo, H. Song, T. Kodama, A. Fukamizu, J. S. Gutkind, G. Y. Koh, and N. Mochizuki
Angiopoietin-1 Induces Kruppel-like Factor 2 Expression through a Phosphoinositide 3-Kinase/AKT-dependent Activation of Myocyte Enhancer Factor 2
J. Biol. Chem., February 27, 2009; 284(9): 5592 - 5601.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. B. Atkins and M. K. Jain
Role of Kruppel-Like Transcription Factors in Endothelial Biology
Circ. Res., June 22, 2007; 100(12): 1686 - 1695.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Hamik, Z. Lin, A. Kumar, M. Balcells, S. Sinha, J. Katz, M. W. Feinberg, R. E. Gerszten, E. R. Edelman, and M. K. Jain
Kruppel-like Factor 4 Regulates Endothelial Inflammation
J. Biol. Chem., May 4, 2007; 282(18): 13769 - 13779.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Methe, M. Balcells, M. del Carmen Alegret, M. Santacana, B. Molins, A. Hamik, M. K. Jain, and E. R. Edelman
Vascular bed origin dictates flow pattern regulation of endothelial adhesion molecule expression
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2167 - H2175.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. A. Boon, J. O. Fledderus, O. L. Volger, E. J.A. van Wanrooij, E. Pardali, F. Weesie, J. Kuiper, H. Pannekoek, P. ten Dijke, and A. J.G. Horrevoets
KLF2 Suppresses TGF-{beta} Signaling in Endothelium Through Induction of Smad7 and Inhibition of AP-1
Arterioscler Thromb Vasc Biol, March 1, 2007; 27(3): 532 - 539.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Hirano
The Roles of Proteinase-Activated Receptors in the Vascular Physiology and Pathophysiology
Arterioscler Thromb Vasc Biol, January 1, 2007; 27(1): 27 - 36.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Thum and J. Bauersachs
Sports or statins for atheroprotection? New insight from Kruppel-like factor 2
Cardiovasc Res, November 1, 2006; 72(2): 193 - 195.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. Ruf
Flow perturbation is linked to endothelial par signaling.
Arterioscler Thromb Vasc Biol, May 1, 2006; 26(5): 962 - 964.
[Full Text] [PDF]